[1] Cui F, Shen L, Li L, et al. Prevention of chronic hepatitis B after 3 decades of escalating vaccination policy, China.Emerg Infect Dis, 2017, 23:765-772.
[2] 中华医学会感染病学分会, GRADE 中国中心. 中国乙型肝炎病毒母婴传播防治指南(2019 年版). 中华传染病杂志,2019, 37:388-396.
[3] 中华医学会感染病学分会, 中华医学会肝病学分会. 慢性乙型肝炎防治指南(2019 年版). 肝脏,2019,24:1335-1356.
[4] Cui F, Woodring J, Chan P, et al. Considerations of anti-viral treatment to interrupt mother-to-child transmission of hepatitis B virus in China. Int J Epidemiol, 2018, 47:1529-1537.
[5] 中华人民共和国国家卫生和计划生育委员会. 国家免疫规划疫苗儿童免疫程序及说明(2016 年版). 中国病毒病杂志,2017,7:81-86.
[6] World Health Organization. Global hepatitis report 2017. http:／／appswhoint／iris／bitstream／10665 ／255016 ／1 ／9789241565455-engpdf？ ua ＝1, accessed on 12 December 2019.
[7] Beasley RP, Hwang LY, Lin CC, et al. Incidence of hepa-titis B virus infections in preschool children in Taiwan. J In-fect Dis, 1982, 146:198204.
[8] World Health Organization. Implementation of hepatitis B birth dose vaccination-worldwide, 2016. Wkly Epidemiol Rec,2018, 93:61-72. |
